<DOC>
	<DOCNO>NCT02171390</DOCNO>
	<brief_summary>The study search answer two question 1 . Is endothelial dysfunction , inflammation insulin resistance patient congenital hypogonadotropic hypogonadism ? 2 . What effect testosterone replacement therapy endothelial dysfunction , inflammation insulin resistance ?</brief_summary>
	<brief_title>Endothelial Dysfunction , Inflammation Insulin Resistance Congenital Hypogonadism Effect Testosteron Replacement Therapy</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Men Treatment naive Hypogonadotrophic hypogonadism Previous history androgen replacement Chronic metabolic disorder</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>26 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Hypogonadism</keyword>
	<keyword>Endothelial dysfunction</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Testosterone replacement therapy</keyword>
</DOC>